NZ337868A - Detection of endometrial cancer using a matrix metalloprotease - Google Patents
Detection of endometrial cancer using a matrix metalloproteaseInfo
- Publication number
- NZ337868A NZ337868A NZ337868A NZ33786898A NZ337868A NZ 337868 A NZ337868 A NZ 337868A NZ 337868 A NZ337868 A NZ 337868A NZ 33786898 A NZ33786898 A NZ 33786898A NZ 337868 A NZ337868 A NZ 337868A
- Authority
- NZ
- New Zealand
- Prior art keywords
- mmp
- uterine
- levels
- endometrial cancer
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
- G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
- G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPO5736A AUPO573697A0 (en) | 1997-03-20 | 1997-03-20 | Diagnosis of endometrial cancer |
| PCT/AU1998/000189 WO1998042865A1 (en) | 1997-03-20 | 1998-03-20 | Detection of endometrial cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ337868A true NZ337868A (en) | 2002-05-31 |
Family
ID=3800039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ337868A NZ337868A (en) | 1997-03-20 | 1998-03-20 | Detection of endometrial cancer using a matrix metalloprotease |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6607894B1 (https=) |
| EP (1) | EP0979304B1 (https=) |
| JP (2) | JP4183757B2 (https=) |
| KR (1) | KR20010006344A (https=) |
| CN (1) | CN1257550A (https=) |
| AT (1) | ATE331039T1 (https=) |
| AU (1) | AUPO573697A0 (https=) |
| CA (1) | CA2284099C (https=) |
| DE (1) | DE69835010T2 (https=) |
| ES (1) | ES2268767T3 (https=) |
| MY (1) | MY119567A (https=) |
| NZ (1) | NZ337868A (https=) |
| WO (1) | WO1998042865A1 (https=) |
| ZA (1) | ZA982403B (https=) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999045147A1 (en) * | 1998-03-05 | 1999-09-10 | Diadexus Llc | A novel method of detecting and monitoring endometrial and uterine cancers |
| AUPQ219799A0 (en) | 1999-08-13 | 1999-09-02 | R. Lurie Pty Ltd | Apparatus for obtaining potological samples |
| US7071164B2 (en) | 2001-08-16 | 2006-07-04 | Kimberly-Clark Worldwide, Inc. | Anti-cancer and wound healing compounds |
| US7186693B2 (en) | 2001-08-16 | 2007-03-06 | Kimberly - Clark Worldwide, Inc. | Metalloproteinase inhibitors for wound healing |
| US6906036B2 (en) | 2001-08-16 | 2005-06-14 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
| US7094754B2 (en) | 2001-08-16 | 2006-08-22 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
| DE10217677A1 (de) | 2002-04-19 | 2003-11-06 | Bayer Ag | Verwendung von Aufhellern zur Herstellung von Streichmassen |
| US7148194B2 (en) | 2002-12-30 | 2006-12-12 | Kimberly-Clark Worldwide, Inc. | Method to increase fibronectin |
| US7189700B2 (en) | 2003-06-20 | 2007-03-13 | Kimberly-Clark Worldwide, Inc. | Anti-chrondrosarcoma compounds |
| US20050112622A1 (en) * | 2003-08-11 | 2005-05-26 | Ring Brian Z. | Reagents and methods for use in cancer diagnosis, classification and therapy |
| US20060003391A1 (en) * | 2003-08-11 | 2006-01-05 | Ring Brian Z | Reagents and methods for use in cancer diagnosis, classification and therapy |
| DK1782068T3 (da) * | 2004-07-23 | 2010-08-02 | Ct De Rech Public De La Sante | Overvågning af hjertesvigt |
| US20080131916A1 (en) * | 2004-08-10 | 2008-06-05 | Ring Brian Z | Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy |
| RU2007133660A (ru) * | 2005-02-09 | 2009-03-20 | Дженентек, Инк. (Us) | Ингибирование шеддинга her2 антагонистами матриксной металлопротеиназы |
| US7504225B2 (en) * | 2005-05-12 | 2009-03-17 | Applied Genomics, Inc. | Reagents and methods for use in cancer diagnosis, classification and therapy |
| RU2304782C1 (ru) * | 2005-12-28 | 2007-08-20 | Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова | Способ прогнозирования рецидива эндометриоидной кисты яичника |
| ES2567079T3 (es) | 2007-11-02 | 2016-04-19 | Momenta Pharmaceuticals, Inc. | Composiciones de polisacáridos que no son anticoagulantes |
| US8569262B2 (en) | 2007-11-02 | 2013-10-29 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
| US8592393B2 (en) | 2007-11-02 | 2013-11-26 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
| AU2010236222B2 (en) * | 2009-04-16 | 2015-10-15 | Momenta Pharmaceuticals, Inc. | Methods of assessing activity of a polysaccharide composition |
| US9046522B2 (en) * | 2009-07-24 | 2015-06-02 | Geadic Biotec, Aie | Markers for endometrial cancer |
| BR112012026542A2 (pt) | 2010-04-16 | 2016-07-12 | Momenta Pharmaceuticals Inc | abordagem seletiva de tecido |
| RU2430371C1 (ru) * | 2010-04-26 | 2011-09-27 | Учреждение Российской академии наук Институт ядерной физики им. Г.И. Будкера Сибирского отделения РАН (ИЯФ СО РАН) | Способ дифференциальной диагностики и прогноза миомы и рака эндометрия |
| CA2795868A1 (en) | 2010-06-17 | 2011-12-22 | Momenta Pharmaceuticals, Inc. | Methods and compositions for modulating hair growth |
| US8455624B2 (en) * | 2011-06-03 | 2013-06-04 | University Of South Alabama | Methods and compositions for detecting endometrial or ovarian cancer |
| CN107389936A (zh) * | 2011-09-22 | 2017-11-24 | 斯隆－凯特林纪念癌症中心 | 检测卵巢癌 |
| ES2691404T3 (es) * | 2012-01-31 | 2018-11-27 | SPEISER, Paul | Diagnóstico no invasivo del cáncer |
| JP2016520613A (ja) | 2013-05-28 | 2016-07-14 | モメンタ ファーマシューティカルズ インコーポレイテッド | 薬学的組成物 |
| AU2015283811A1 (en) * | 2014-07-02 | 2017-02-09 | Bionomics Limited | Predictive biomarkers |
| CA2975737A1 (en) * | 2015-02-06 | 2016-08-11 | Quest Diagnostics Investments Llc | Compositions and methods for determining endometrial cancer prognosis |
| EP3452829B1 (en) * | 2016-05-04 | 2024-01-24 | Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca | Perm as marker of endometrial cancer |
| IN202021002695A (https=) | 2020-01-21 | 2021-07-23 | ||
| CN112961921B (zh) * | 2021-03-26 | 2022-07-01 | 中国医学科学院北京协和医院 | 一种用于判断早期子宫内膜癌预后的制剂及复发风险模型 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5280106A (en) * | 1988-05-20 | 1994-01-18 | Liotta Lance A | Matrix metalloproteinase peptides: role in diagnosis and therapy |
| US5324634A (en) | 1992-03-31 | 1994-06-28 | The Research Foundation Of State University Of New York | Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer |
| WO1994005807A1 (en) * | 1992-08-28 | 1994-03-17 | Dickson Robert B | Matrix-degrading metalloproteinase |
| EP0674710B1 (en) * | 1992-11-16 | 2003-05-02 | Cancer Research Fund Of Contra Costa | Peptides with broad neoplastic specificity |
-
1997
- 1997-03-20 AU AUPO5736A patent/AUPO573697A0/en not_active Abandoned
-
1998
- 1998-03-20 DE DE69835010T patent/DE69835010T2/de not_active Expired - Lifetime
- 1998-03-20 MY MYPI98001218A patent/MY119567A/en unknown
- 1998-03-20 CN CN98805312A patent/CN1257550A/zh active Pending
- 1998-03-20 EP EP98909221A patent/EP0979304B1/en not_active Expired - Lifetime
- 1998-03-20 ZA ZA982403A patent/ZA982403B/xx unknown
- 1998-03-20 JP JP54453698A patent/JP4183757B2/ja not_active Expired - Fee Related
- 1998-03-20 NZ NZ337868A patent/NZ337868A/en not_active IP Right Cessation
- 1998-03-20 ES ES98909221T patent/ES2268767T3/es not_active Expired - Lifetime
- 1998-03-20 KR KR1019997009429A patent/KR20010006344A/ko not_active Withdrawn
- 1998-03-20 WO PCT/AU1998/000189 patent/WO1998042865A1/en not_active Ceased
- 1998-03-20 AT AT98909221T patent/ATE331039T1/de not_active IP Right Cessation
- 1998-03-20 CA CA2284099A patent/CA2284099C/en not_active Expired - Fee Related
- 1998-03-20 US US09/381,454 patent/US6607894B1/en not_active Expired - Fee Related
-
2007
- 2007-01-09 JP JP2007001867A patent/JP2007202556A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| DE69835010D1 (de) | 2006-08-03 |
| JP4183757B2 (ja) | 2008-11-19 |
| JP2002501613A (ja) | 2002-01-15 |
| CA2284099A1 (en) | 1998-10-01 |
| ATE331039T1 (de) | 2006-07-15 |
| MY119567A (en) | 2005-06-30 |
| EP0979304B1 (en) | 2006-06-21 |
| CA2284099C (en) | 2010-04-27 |
| DE69835010T2 (de) | 2007-06-06 |
| EP0979304A1 (en) | 2000-02-16 |
| ES2268767T3 (es) | 2007-03-16 |
| US6607894B1 (en) | 2003-08-19 |
| EP0979304A4 (en) | 2003-06-11 |
| CN1257550A (zh) | 2000-06-21 |
| ZA982403B (en) | 1998-10-21 |
| AUPO573697A0 (en) | 1997-04-10 |
| JP2007202556A (ja) | 2007-08-16 |
| WO1998042865A1 (en) | 1998-10-01 |
| KR20010006344A (ko) | 2001-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6607894B1 (en) | Matrix metalloproteinase levels as indicators of endometrial cancer | |
| Bianco Jr et al. | Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade. | |
| CN112601961B (zh) | 通过尿液生物标志物的方式体外诊断前列腺癌的方法 | |
| JP5155309B2 (ja) | 患者の循環液中のＭＭＰ−７の測定を利用した転移した膀胱ガンを診断およびモニターするためのｉｎｖｉｔｒｏ方法 | |
| Lopata et al. | Detection of endometrial cancer by determination of matrix metalloproteinases in the uterine cavity | |
| US6221623B1 (en) | Biochemical methods for detecting cervical dysplasia and cancer | |
| Harada et al. | Expression of matrix metalloproteinase in the fluids of renal cystic lesions | |
| Yang et al. | A Significant Elevation of Plasma Level of Matrix Metalloproteinase—9 in Patients With High-Grade Intraepithelial Neoplasia and Early Squamous Cell Carcinoma of the Uterine Cervix | |
| WO1995004281A1 (en) | Quantitative method of measuring cancer cell urokinase and metastatic potential | |
| AU728286B2 (en) | Detection of endometrial cancer | |
| Nordström et al. | Laminin-5 g 2 chain as an invasivity marker for uni-and multifocal lesions in the lower anogenital tract | |
| US20070269831A1 (en) | Method for Early Detection of Ovarian Cancer | |
| MXPA99008616A (en) | Detection of endometrial cancer | |
| Bollmann et al. | Quantitative molecular grading of bladder tumours: a tool for objective assessment of the biological potential of urothelial neoplasias | |
| Bazzett et al. | Urinary matrix metalloproteinases as a potential screening test for gynecologic malignancies | |
| US20080213815A1 (en) | Diagnosing breast cancer by seprase level | |
| WO2000023613A1 (en) | A method of assessing a matter associated with parturition in a pregnant individual | |
| Vries et al. | 1826: Development of Prostate Specific Antigen Over Time in Males with Screen Detected Adenocarcinoma of the Prostate Following a Watchful Waiting Policy | |
| Degnim et al. | Refining risk assessment in women with atypical hyperplasia | |
| Kapucuoglu et al. | Expression of gelatinase (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinoma | |
| Datta | PSA in Prostate Cancer Diagnosis | |
| Purified | Improving the Clinical Utility of the Serum PSA Test | |
| Talvensaari-Mattila | MMP-2 immunoreactive protein in breast carcinoma and neoplastic cervical lesions: mMP-2 is a new prognostic factor in breast carcinoma | |
| Sarkar et al. | Role of Morphometry and Proliferative Activity Markers in Assessment of Endometrial Glandular Lesions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AVOD | Application void | ||
| RENW | Renewal (renewal fees accepted) | ||
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| ASS | Change of ownership |
Owner name: DIAGNOTECH PTY LTD, AU Free format text: OLD OWNER(S): DIAGNOTECH PTY LTD; PRINCE HENRY'S INSTITUTE OF MEDICAL RESEARCH; THE UNIVERSITY OF MELBOURNE |
|
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| EXPY | Patent expired |